Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Animal Models of Pneumococcal pneumonia.

Borsa N, Pasquale MD, Restrepo MI.

Int J Mol Sci. 2019 Aug 28;20(17). pii: E4220. doi: 10.3390/ijms20174220. Review.

2.

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.

Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, Rupp J, González Del Castillo J, Blasi F, Aliberti S, Restrepo MI; GLIMP Investigators .

Clin Infect Dis. 2019 Apr 24;68(9):1482-1493. doi: 10.1093/cid/ciy723.

3.

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.

Gramegna A, Sotgiu G, Di Pasquale M, Radovanovic D, Terraneo S, Reyes LF, Vendrell E, Neves J, Menzella F, Blasi F, Aliberti S, Restrepo MI; GLIMP Study Group.

BMC Infect Dis. 2018 Dec 18;18(1):677. doi: 10.1186/s12879-018-3565-z.

4.

An international perspective on hospitalized patients with viral community-acquired pneumonia.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, Di Pasquale MF, Gramegna A, Terraneo S, Blasi F, Santus P, Aliberti S, Reyes LF, Restrepo MI; GLIMP Study Group.

Eur J Intern Med. 2019 Feb;60:54-70. doi: 10.1016/j.ejim.2018.10.020. Epub 2018 Nov 4.

PMID:
30401576
5.

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis.

Sotgiu G, Aliberti S, Gramegna A, Mantero M, Di Pasquale M, Trogu F, Saderi L, Blasi F.

Respir Res. 2018 Oct 23;19(1):205. doi: 10.1186/s12931-018-0905-x.

6.

Emerging antibacterial and antiviral drugs for treating respiratory tract infections.

Mantero M, Rogliani P, Cazzola M, Blasi F, Di Pasquale M.

Expert Opin Emerg Drugs. 2018 Sep;23(3):185-199. doi: 10.1080/14728214.2018.1504020. Epub 2018 Jul 30. Review.

PMID:
30032674
7.

Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project.

De Pascale G, Ranzani OT, Nseir S, Chastre J, Welte T, Antonelli M, Navalesi P, Garofalo E, Bruni A, Coelho LM, Skoczynski S, Longhini F, Taccone FS, Grimaldi D, Salzer HJF, Lange C, Froes F, Artigas A, Díaz E, Vallés J, Rodríguez A, Panigada M, Comellini V, Fasano L, Soave PM, Spinazzola G, Luyt CE, Alvarez-Lerma F, Marin J, Masclans JR, Chiumello D, Pezzi A, Schultz M, Mohamed H, Van Der Eerden M, Hoek RAS, Gommers DAMPJ, Pasquale MD, Civljak R, Kutleša M, Bassetti M, Dimopoulos G, Nava S, Rios F, Zampieri FG, Povoa P, Bos LD, Aliberti S, Torres A, Martín-Loeches I.

ERJ Open Res. 2017 Nov 17;3(4). pii: 00092-2017. doi: 10.1183/23120541.00092-2017. eCollection 2017 Oct.

8.

Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations.

Mantero M, Tarsia P, Gramegna A, Henchi S, Vanoni N, Di Pasquale M.

Multidiscip Respir Med. 2017 Oct 5;12:26. doi: 10.1186/s40248-017-0106-3. eCollection 2017. Review.

9.

Acute exacerbations of COPD: risk factors for failure and relapse.

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 8;12:2687-2693. doi: 10.2147/COPD.S145253. eCollection 2017. Review.

10.

Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy.

Mantero M, Aliberti S, Azzari C, Moriondo M, Nieddu F, Blasi F, Di Pasquale M.

Ther Adv Respir Dis. 2017 Oct;11(10):403-407. doi: 10.1177/1753465817728479. Epub 2017 Aug 31.

11.

Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy.

Di Pasquale M, Aliberti S, Azzari C, Moriondo M, Nieddu F, Blasi F, Mantero M.

SAGE Open Med. 2017 Jul 16;5:2050312117720058. doi: 10.1177/2050312117720058. eCollection 2017.

12.

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?

Di Pasquale M, Aliberti S, Mantero M, Bianchini S, Blasi F.

Int J Mol Sci. 2016 Feb 25;17(3):287. doi: 10.3390/ijms17030287. Review.

13.

Endotracheal tubes for critically ill patients: an in vivo analysis of associated tracheal injury, mucociliary clearance, and sealing efficacy.

Li Bassi G, Luque N, Martí JD, Aguilera Xiol E, Di Pasquale M, Giunta V, Comaru T, Rigol M, Terraneo S, De Rosa F, Rinaudo M, Crisafulli E, Peralta Lepe RC, Agusti C, Lucena C, Ferrer M, Fernández L, Torres A.

Chest. 2015 May;147(5):1327-1335. doi: 10.1378/chest.14-1438.

PMID:
25500677
14.

Assessment of severity of ICU-acquired pneumonia and association with etiology.

Di Pasquale M, Ferrer M, Esperatti M, Crisafulli E, Giunta V, Li Bassi G, Rinaudo M, Blasi F, Niederman M, Torres A.

Crit Care Med. 2014 Feb;42(2):303-12. doi: 10.1097/CCM.0b013e3182a272a2.

PMID:
23989176
15.

Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.

Di Pasquale M, Esperatti M, Crisafulli E, Ferrer M, Bassi GL, Rinaudo M, Escorsell A, Fernandez J, Mas A, Blasi F, Torres A.

Intensive Care Med. 2013 Oct;39(10):1776-84. doi: 10.1007/s00134-013-3025-6. Epub 2013 Aug 2.

PMID:
23907496
16.

Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.

Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F.

Clin Infect Dis. 2012 Feb 15;54(4):470-8. doi: 10.1093/cid/cir840. Epub 2011 Nov 21.

PMID:
22109954

Supplemental Content

Loading ...
Support Center